First slide
Cytocell Logo

Product summary

  • Technology FISH
  • Application Solid tumour
  • Areas of interest Lymphoma
  • Region 14q32.33
    18q21.31-q21.32
  • Label    
  • Product No. LPS 034 (10 tests)
    LPS 034-S (5 tests)
  • Intended use In vitro diagnostic. This product is intended to be used on Carnoy’s solution (3:1 methanol/acetic acid) fixed haematological samples, or formalin-fixed paraffin-embedded (FFPE) tissues. Disease information supported by the literature and is not a reflection of the intended purpose of this product.

Chromomaps

Overview

Probe specification

  • IGH, 14q32.33, Green
  • MALT1, 18q21.31-q21.32, Red

The IGH/MALT1 product consists of probes, labelled in green, covering the Constant, J, D and Variable segments of the IGH gene, and MALT1 probes, labelled in red. The MALT1 probe mix contains four probes, two 171kb, 228kb probes positioned centromeric to the MALT1 gene and two 132kb, 306kb probes positioned telomeric to the MALT1 gene.

 

Probe information

The t(14;18)(q32;q21) involving the Immunoglobulin heavy chain locus (IGH) at 14q32 and the Mucosa Associated Lymphoid Tissue Lymphoma Translocation gene 1 (MALT1) at 18q21 is a recurrent abnormality in MALT lymphoma1.

Extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue is listed as a distinct clinicopathologic entity. MALT lymphomas comprise 7.6% of all non-Hodgkin lymphoma's (NHLs) and represents 1 of the 6 most common NHLs2. MALT lymphomas are characterised by a proliferation of neoplastic marginal zone-related cells that invade the epithelial structures to generate lymphoepithelial lesions and colonise reactive lymphoid follicles3. t(14;18)/IGH-MALT1- positive MALT lymphomas originate in sites such as the liver, skin, ocular adnexa, or salivary glands1. The molecular characteristics of the t(14;18) resemble those found in the t(14;18)/IGH-BCL2 (follicular lymphoma) and t(11;14)/MALT1-IGH (mantle cell lymphoma), suggesting that these translocations could be generated by common pathomechanisms involving illegitimate V(D)J-mediated recombination of IGH as well as non-homologous end joining (NHEJ) or alternative NHEJ repair pathways1.

What our customers say

References

  1. Murga Penas EM et al., Blood 2010;115(11):2214-9
  2. Streubel B et al., Blood 2003;101:2335-2339
  3. Bacon et al., J Clin Pathol 2007;60:361–372

FFPE tissue preparation and FISH protocol

Select a protocol step to view:

Heat pretreatment

Heat pretreatment Thumbnail
  • Heat 500ml Tissue Pretreatment Solution (Reagent 1) until it is either boiling or 96-98°C.
  • Heat slides for 15 minutes (Note: different incubation times may be required depending on tissue fixation. A 15 minute incubation is a recommended starting point).
  • Wash in PBS or dH2O at room temperature (RT) for 2 x 3 minutes.
Solid tumour FFPE FISH protocol Video Image
Play Icon

Solid tumour FFPE FISH protocol

Request a quote for this product

FISH resources & support